Practical transfer pricing solutions and hands-on support for companies navigating the complexities of cross-border tax.
Responsive, proactive, and relationship-driven — your priorities come first.
From planning and benchmarking to documentation, APAs, and audit defense, we support the full transfer pricing lifecycle.
Every engagement is led by seasoned transfer pricing specialists who bring deep expertise — and take the time to make it make sense for your team.
We deliver clear, business-aligned transfer pricing frameworks — from planning through audit defense.
We provide practical transfer pricing solutions for businesses
operating across borders.
We support organizations across the full transfer pricing lifecycle — from planning and implementation through compliance and controversy management — connecting strategy with business objectives and translating decisions into practical, defensible outcomes.
See the full lifecycle →Beyond the core transfer pricing lifecycle, we provide specialized support for high-impact decisions — from risk assessments and IP valuation to M&A due diligence and U.S. domestic transfer pricing matters.
See additional services →We bring deep transfer pricing experience across a range of industries, combining technical expertise with an understanding of how value is created in your sector.
Supporting complex global supply chains, R&D cost-sharing, and manufacturing arrangements across the automotive value chain.
Advising on IP development and migration, R&D structures, and intercompany software and services arrangements.
Aligning transfer pricing with production, distribution, and supply chain structures.
Supporting distribution and sourcing structures, brand and marketing intangibles, and cross-border retail operations.
Aligning transfer pricing with brand ownership, distribution models, and marketing intangibles.
Advising on intercompany financing, guarantees, and treasury arrangements.
Advising sponsors and portfolio companies on transfer pricing considerations across acquisitions and integrations.
IP migration, R&D cost-sharing, and licensing arrangements across pharma, biotech, and medical device value chains.